Physician profile
Bryan Scott
NPI 1285082248
$19,930.36
in general payments reported to CMS, 2019-2025
10 companies · $1,520 in 2025
The $1,520 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2021: $447 · 2022: $4,254 · 2023: $7,548 · 2024: $5,955 · 2025: $1,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,210 · Travel and Lodging: $3,657 · Education: $3,600 · Consulting Fee: $3,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,209.82 |
| Travel and Lodging | $3,657.39 |
| Education | $3,600.00 |
| Consulting Fee | $3,555.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,148.37 | 2022-2023 | Journey II, Hip7, Redapt |
| Stryker Corporation | $4,682.41 | 2021-2025 | Mako, Accolade, Gamma |
| Medical Device Business Services, INC. | $3,715.84 | 2019-2024 | Na |
| Lightbody Medical Technologies INC | $495.01 | 2024-2025 | |
| Depuy Synthes Sales INC. | $411.52 | 2019-2025 | Tfn-Advance, Lcp, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $285.44 | 2022-2023 | Affixus, G7 |
| Shalby Advanced Technologies, INC. | $108.65 | 2024 | Cks - Vitalite, Consensus Knee System |
| Globus Medical, INC. | $32.25 | 2023 | Distal Femur Plate System |
| Medwest Associates | $25.90 | 2023 | |
| Exactech, INC. | $24.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.